朊病毒病治疗方法的研究进展

doi:10.19586/j.2095-2341.2021.0156

生物技术进展 ›› 2022, Vol. 12 ›› Issue (2): 229-235.DOI: 10.19586/j.2095-2341.2021.0156

朊病毒病治疗方法的研究进展

李书翔(), 安丽萍, 梁德娟, 王凯旋, 赵建国()

海南大学生命科学学院，海口 570228

收稿日期:2021-09-22 接受日期:2021-11-12 出版日期:2022-03-25 发布日期:2022-03-28
通讯作者: 赵建国
作者简介:李书翔 E-mail：2060709772@qq.com；
基金资助:
海南省重点研发计划项目(ZDYF2019092)

Research Progress on the Treatment of Prion Disease

Shuxiang LI(), Liping AN, Dejuan LIANG, Kaixuan WANG, Jianguo ZHAO()

School of Life Sciences，Hainan University，Haikou 570228，China

Received:2021-09-22 Accepted:2021-11-12 Online:2022-03-25 Published:2022-03-28
Contact: Jianguo ZHAO

摘要/Abstract

摘要：

朊病毒是一种由体内正常朊蛋白转化形成的传染性蛋白质，朊病毒病是由朊病毒引发的致命性神经退行性疾病。目前临床虽然尚无治疗朊病毒病的方法，但是大量的研究者已从多个角度进行研究，并取得了一定进展。对近期有关传统化学药物、基因治疗方法、免疫学治疗方法和同源朊蛋白的朊病毒病治疗方法进行了综述，并重点分析了新型靶向细胞内信号通路药物以及有潜在利用价值的线粒体相关朊病毒胞内作用信号通路，旨在为朊病毒新的研究方向提供理论依据，从而促进朊病毒病治疗方法应用于临床。

关键词: 朊病毒病, 朊蛋白, 基因治疗, 免疫治疗

Abstract:

Prions are infectious proteins formed by normal prion proteins in vivo， and prion diseases are a class of fatal neurodegenerative diseases triggered by prions. At present， although there is no clinical method to treat prion disease， a large number of researchers have studied from many angles and made some progress. This article provided a brief illustration of recent prion disease treatment options related to traditional chemical drugs， gene therapy， immunotherapy and homologous prion proteins， with an emphasis on novel drugs that target intracellular signaling pathways as well as intracellular signaling pathways of mitochondria associated with prion proteins with potential utility. This paper aimed to provide a theoretical basis for the new research direction of prion， in order to promote the clinical application of prion treatment methods.

Key words: prion disease, prion proteins, signaling pathway, gene therapy, immunotherapy

中图分类号:

R373

李书翔, 安丽萍, 梁德娟, 王凯旋, 赵建国. 朊病毒病治疗方法的研究进展[J]. 生物技术进展, 2022, 12(2): 229-235.

Shuxiang LI, Liping AN, Dejuan LIANG, Kaixuan WANG, Jianguo ZHAO. Research Progress on the Treatment of Prion Disease[J]. Current Biotechnology, 2022, 12(2): 229-235.

参考文献 54

1	张珠明,汪仁莉,赵德明.朊病毒病治疗的研究进展[J].中国兽医杂志,2012,48(3):58-60.
2	秦笙,彭健愉,柏彩英,等.黄芩素对朊蛋白PrP106-126片段引起的神经毒性保护作用研究[J].中国医药导报,2019,16(34):7-10, 181.
3	杨微,陈志宝,陈操,等.桦褐孔菌乙醇粗提物对朊病毒复制的抑制作用[J].现代食品科技,2021,37(7): 8-13, 7.
4	CHAO H, CAO C, JIA C, et al.. The low levels of nerve growth factor and its upstream regulatory kinases in prion infection is reversed by resveratrol[J]. Neurosci. Res., 2021, 162: 52-62..
5	周冬花.芷类对朊病毒体外复制的影响及作用机制研究[D].北京:中国疾病预防控制中心,2019.
6	李辉,卜祥龙,窦爽,等.淫羊藿提取物对酵母朊病毒[PSI⁺]治愈的影响[J].微生物学杂志, 2013,33(5):42-45.
7	张艳,刘宴村,宋有涛.钩藤提取物对感染朊病毒酵母模型的治疗作用[J].动物医学进展,2015,36(9):84-87.
8	SOSHI K. Targeting the endoplasmic reticulum in prion disease treatment: breakthroughs and challenges[J]. Res. Rep. Biochem., 2015, 2015(5): 31-38.
9	MALLUCCI G, DICKINSON A, LINEHAN J, et al.. Depleting neuronal Prp in prion infection prevents disease and reverses spongiosis[J]. Science, 2003, 302(5646): 871-874.
10	HALLIDAY M, RADFORD H, SEKINE Y, et al.. Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity[J/OL]. Cell Death Dis., 2015, 6(3): e1672[2020-11-12]. .
11	HALLIDAY M, HELOIS R, ZENTS K A M, et al.. Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice[J]. Brain, 2017, 140(6): 1768-1783.
12	DAS I, KRZYZOSIAK A, SCHNEIDER K, et al.. Preventing proteostasis diseases by selective inhibitionof a phosphatase regulatory subunit[J]. Science, 2015, 348(6231): 239-242.
13	许尹.自噬系统在朊病毒感染过程中的变化规律及机制研究[D].北京:中国疾病预防控制中心,2013.
14	CORTES C J, QIN K, COOK J, et al.. Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease[J]. J. Neurosci., 2012, 32(36): 12396-12405.
15	GRZMIL M, HEMMINGS B A. Overcoming resistance to rapalogs in gliomas by combinatory therapies[J]. Biochim. Biophys. Acta, 2013, 1834(7): 1371-1380.
16	MI W, YE Q, LIU S, et al.. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis[J]. Oncotarget, 2015, 6(16): 13962-13977.
17	杨威.PRAS40缓解神经毒性多肽诱导神经元凋亡机制的研究[D].北京:中国农业大学,2017.
18	KARAPETYAN Y E, SFERRAZZA G F, ZHOU M, et al.. Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents[J]. Proc. Natl. Acad. Sci. USA, 2013, 110(17):7044-7049.
19	YUN S W, ERTMER A, FLECHSIG E, et al.. The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery[J]. J. Neurovirol., 2007, 13(4): 328-337.
20	HEISEKE A, AGUIB Y, RIEMER C, et al.. Lithium induces clearance of protease resistat prion protein in prion-infected cells by induction of autophagy[J]. J. Neurochem., 2009, 109(1): 25-34.
21	宋志琦.REST在朊病毒疾病模型中神经保护作用机制的研究[D].北京:中国农业大学,2018.
22	张腾龙,陈志宝,鞠传静,等.朊病毒病治疗的研究进展[J].中国人兽共患病学报,2015,31(1):54-59.
23	阿达莱提·买买提明,武月章,谢姆斯耶·吾拉音,等.线粒体靶向抗氧化剂Mitoquinone和积雪草酸对朊病毒感染的神经细胞的治疗作用研究[J].病毒学报, 2019, 35(2): 247-254.
24	FARIS R, MOORE R A, WARD A, et al.. Mitochondrial respiration is impaired during late stage hamster prion infection[J/OL]. J. Virol., 2017, 91(18): e00524-17[2020-12-01]. .
25	杨晓东,陈利娜,董小平,等.线粒体功能异常与朊病毒病的关系[J].中国病毒病杂志, 2015(4): 313-316.
26	ANSOLEAGA B, GARCIA-ESPARCIA P, LLORENS F, et al.. Altered mitochondria, protein synthesis machinery, and purine metabolism are molecular contributors to the pathogenesis of Creutzfeldt-Jakob disease[J]. J. Neuropathol. Exp. Neurol., 2016, 75(8): 755-769.
27	LEE D W, SOHN H O, LIM H B, et al.. Alteration of free radical metabolism in the brain of mice infected with scrapie agent[J]. Free Radic. Res., 1999, 30(6): 499-507.
28	PARK Y G, JEONG J K, MOON M H, et al.. Insulin-like growth factor-1 protects against prion peptide-induced cell death in neuronal cells via inhibition of Bax translocation[J]. Int. J. Mol. Med., 2012, 30(5): 1069-1074.
29	高利萍.E200K突变朊病毒病的疾病特征及朊病毒感染过程中线粒体自噬的研究[D].北京:中国疾病预防控制中心,2020.
30	李超斯.DLP1调控线粒体动力学失衡在朊病毒疾病模型中的作用机制[D].北京:中国农业大学,2018.
31	程胖.利用RNAi抑制牛胎儿成纤维细胞中prnp基因的表达[D].咸阳:西北农林科技大学, 2010.
32	PFLANZ H, VANA K, MITTEREGGER G, et al.. Microinjection of lentiviral vectors expressing small interfering RNAs directed against laminin receptor precursor mRNA prolongs the pre-clinical phase in scrapie-infected mice[J]. J. Gen. Virol., 2009, 90(Pt 1): 269-74.
33	RAYMOND G J, ZHAO H T, RACE B, et al.. Antisense oligonucleotides extend survival of prion-infected mice[J/OL]. JCI Insight, 2019, 5(16): e131175[2021-02-05]. .
34	MINIKEL E V, ZHAO H T, LE J, et al.. Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints[J]. Nucl. Acids Res., 2020, 48(19): 10615-10631.
35	WUERTZER C A, SULLIVAN M A, QIU X, et al.. CNS delivery of vectored prion-specific single-chain antibodies delays disease onset[J]. Mol. Ther., 2008, 16(3): 481-486.
36	JONES D R, TAYLOR W R, BATE C, et al.. A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines[J/OL]. PLoS ONE, 2010, 5(3): e9804[2020-12-11]. .
37	MONTRASIO F, FRIGG R, GLATZEL M, et al.. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells[J]. Science, 2000, 288(5469): 1257-1259.
38	FERNANDEZ-BORGES N, BRUN A, WHITTON J L, et al.. DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge[J]. J. Virol., 2006, 80(20): 9970-9976.
39	BACHY V, BALLERINI C, GOURDAIN P, et al.. Mousevaccination with dendritic cells loaded with prion protein peptides overcomes tolerance and delays scrapie[J]. Gen. Virol., 2010, 91(Pt 3): 809-820.
40	ABDELAZIZ D H, THAPA S, ABDULRAHMAN B, et al. Immunization of cervidizedtransgenic mice with multimeric deer prion protein induces self-antibodies that antagonize chronic wasting disease infectivity in vitro[J/OL]. Sci. Rep., 2017, 7(1): 10538[2021-03-10]. .
41	ABDELAZIZ D H, THAPA S, BRANDON J, et al.. Recombinant prion protein vaccination of transgenic elk PrP mice and reindeer overcomes self-tolerance andprotects mice against chronic wasting disease[J]. Biol. Chem., 2018, 293(51): 19812-19822.
42	SOLFOROSI L, CRIADO J R, MCGAVERN D B, et al.. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo[J]. Science, 2004, 303(5663): 1514-1516.
43	WANG F, WANG X, ORRÚ C D, et al.. Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity[J/OL]. PLoS Pathog., 2017, 13(7):e1006491[2021-04-10]. .
44	LI Q, WANG F, XIAO X, et al.. Structural attributes of mammalian prion infectivity: insights from studies with synthetic prions[J]. J. Biol. Chem., 2018, 293(48):18494-18503.
45	SKINNER P J, KIM H O, DAMANI B, et al.. Treatment of prion disease with heterologous prion proteins[J/OL]. PLoS ONE, 2015, 10(7): e0131993[2021-04-22]. .
46	刘怡芳,吕杰.克雅病生物标本检测研究进展[J].职业与健康, 2020,36(5):697-700.
47	ERAÑA H, CHARCO J M, GONZÁLEZ-MIRANDA E, et al.. Detection of pathognomonic biomarker PrPSc and the contribution of cell free-amplification techniques to the diagnosis of prion diseases[J/OL]. Biomolecules, 2020, 10(3): 469[2021-04-30]. .
48	ASCARI L M, ROCHA S C, GONALVEs P B, et al.. Challenges and advances in antemortem diagnosis of human transmissible spongiform encephalopathies[J/OL]. Front. Bioeng. Biotechnol., 2020, 8: 585896[2021-04-30]. .
49	秦川,张连峰.常见和新发传染病动物模型[M].北京:中国协和医科大学出版社,2012:178-179.
50	王冬冬,杨利峰,赵德明,等.传染性海绵状脑病果蝇模型研究进展[J/OL].中国实验动物学报,2017:1-5[2021-10-30]. .
51	马月,高利萍,肖康,等.核转录因子-κB(p65)在羊瘙痒因子139A感染小鼠脑组织中变化的研究[J].疾病监测, 2018,33(1):32-36.
52	张仁庆. 朊病毒病中CaM信号通路变化特点的研究[D]. 大庆:黑龙江八一农垦大学,2017.
53	孙静.经典Wnt通路在朊病毒病中抑制及其机制研究[D].北京:中国疾病预防控制中心,2016.
54	SHAH S Z A. FK506与米诺环素联合用药对朊病毒感染金黄地鼠治疗作用研究[D].北京:中国农业大学,2018.

[1]	彭灿灿, 王惠明. 适合免疫治疗的大鼠抗肾小球基底膜肾炎模型的建立[J]. 生物技术进展, 2022, 12(3): 473-478.
[2]	权春菊, 郑忠亮. CRISPR/Cas及其衍生编辑技术在基因治疗中的应用进展[J]. 生物技术进展, 2021, 11(4): 518-525.
[3]	杜梦潭,刘兴健,胡小元,张志芳,李轶女. 腺相关病毒的生产方式及其在基因治疗中的应用[J]. 生物技术进展, 2019, 9(4): 326-331.
[4]	刘梦昱,谢飞,张鑫,赵鹏翔,. 胶质母细胞瘤免疫治疗研究进展[J]. 生物技术进展, 2019, 9(3): 223-230.
[5]	李耿,刘晓志,王志明,高健. 双特异性抗体药物应用进展[J]. 生物技术进展, 2015, 5(6): 420-424.
[6]	赵丽琴,席斌,彭华松. 腺相关病毒(AAV)载体研究进展[J]. 生物技术进展, 2012, 2(2): 110-115.

朊病毒病治疗方法的研究进展

Research Progress on the Treatment of Prion Disease

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 54

相关文章 6

编辑推荐

Metrics

本文评价